Answer
Oct 17, 2024 - 10:00 AM
The active ingredient in Vyzulta is latanoprostene bunod. This component is essential for the drug's mechanism of reducing intraocular pressure.
Do you have the same question? Follow this Question
Oct 17, 2024 - 10:00 AM